26 February 2018 Subject: Management Discussion and Analysis for the Year Ended December 31, 2017 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company Limited
15 May 2019 Subject: Management Discussion and Analysis for the 3-Month Period Ended March 31, 2019 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company Limited
15 May 2018 Subject: Management Discussion and Analysis for the 3-Month Period Ended March 31, 2018 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company Limited
14 August 2018 Subject: Management Discussion and Analysis for the Six-Month Period Ended June 30, 2018 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company
No. CC20181103ELE November 12, 2018 Re: Clarification of the changes in operation performance for the third quarter and the nine- month period ended 30 September 2018 Attn: The President The Stock
14 November 2018 Subject: Management Discussion and Analysis for the Nine-Month Period Ended September 30, 2018 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public
, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like
No No. CC20200806ELE Aug 13, 2020 Re: Clarification of the changes in operation performance for the second quarter and the first half ended 30 June 2020 Attn: The President The Stock Exchange of
No. INGRS066 30 March 2021 Subject : Management Discussion & Analysis (MD&A) for the consolidated financial statements for the financial year ended 31 January 2021 To : The President The Stock
No. CC20191103ELE November 12, 2019 Re: Clarification of the changes in operation performance for the third quarter and the nine- month period ended 30 September 2019 Attn: The President The Stock